Acute administration of typical and atypical antipsychotics reduces EEG gamma power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in gamma power
Nigel C Jones, Maya Reddy, Paul Anderson, Michael R Salzberg, Terence J O'Brien, Didier Pinault
International Journal of Neuropsychopharmacology | OXFORD UNIV PRESS | Published : 2012
This work was supported by a University of Melbourne Joint Projects grant (N.J. and D. P.). N.J. is supported by an NHMRC Career Development Award.